Analytical Chemistry Lab & Testing Services

Analytical method development is the process of designing and optimizing a testing procedure that accurately measures a specific attribute of a drug substance or drug product, such as potency, purity, impurity levels, or dissolution rate. The goal is to produce a method that is specific to the molecule being tested, sensitive enough to detect relevant impurities, and robust enough to perform reliably across different instruments, analysts, and laboratories. For pharmaceutical development, this typically involves HPLC lab techniques including U/HPLC and LC-MS, alongside orthogonal methods for characterizing critical quality attributes such as particle size, water content, and pH.

Pharmaceutical method validation is the formal process of demonstrating that a developed method does what it is designed to do consistently and reproducibly. ICH method validation follows the guidelines set out in ICH Q2(R2), which defines the validation parameters that must be established before a method can be used for GMP analytical testing or regulatory submissions. These parameters include specificity, linearity, accuracy, precision, range, detection limit, quantitation limit, and robustness. A method that has not been properly validated to these standards will not be accepted by the FDA or other global regulatory authorities, regardless of how well it performs in the lab.

The distinction between the two phases matters strategically. Analytical method development is iterative and exploratory and happens early in the drug development lifecycle, often in parallel with formulation work, and is refined as the drug product evolves. Method validation is formal, controlled, and occurs once the method is considered fit for purpose and must be thoroughly documented to support IND, NDA, and global regulatory filings. Stability-indicating methods, which are designed to detect degradation products that form under stress conditions, must also be developed and validated to demonstrate that the analytical procedure can distinguish intact drug from its breakdown products.

CMC Pharma provides fully integrated analytical method development and validation services, from early feasibility through submission-ready validation packages. Our analytical chemistry lab performs both phases under one roof, ensuring scientific continuity, regulatory alignment, and efficient timelines for your program.